Haematological malignancies following temozolomide treatment for paediatric high-grade glioma
Publié dansEuropean Journal of Cancer, vol. 81, p. 1-8
Date de publication2017
Résumé
Mots-clés
- Adolescent
- Antineoplastic Agents
- Alkylating/adverse effects
- Austria/epidemiology
- Child
- Child
- Preschool
- Dacarbazine/adverse effects/analogs & derivatives
- Female
- Follow-Up Studies
- Germany/epidemiology
- Glioma/drug therapy
- Hematologic Neoplasms/chemically induced/epidemiology
- Humans
- Incidence
- Infant
- Kaplan-Meier Estimate
- Male
- Switzerland/epidemiology
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
KARREMANN, Michael et al. Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. In: European Journal of Cancer, 2017, vol. 81, p. 1–8. doi: 10.1016/j.ejca.2017.04.023
Fichiers principaux (1)
Article (Published version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiants
- PID : unige:107413
- DOI : 10.1016/j.ejca.2017.04.023
- PMID : 28586748
ISSN du journal0959-8049